TrialCancer immunology, immunotherapy : CII2018

Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer.

Hideki Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.